Submit a case
Home - About VASCERN - Structure and Governance - Working Groups - Rare Disease Working Groups - Neurovascular Diseases (NEUROVASC-WG) - Clinical Decision Support Tools - Clinical Practice Guidelines (CPGs) adopted
Neurovascular Diseases (NEUROVASC-WG)
Introduction Diseases covered
Expert & Centers
Experts Centers
Clinical Decision Support Tools
Patient Pathways Do’s and Don’ts Clinical Practice Guidelines (CPGs) adopted Clinical Expert Consensus Statements Written Clinical Outcome Measures
Registry
Research
Clinical Trials/Observational Studies Research Publications
Training and Education
E-Learning Pills of Knowledge (PoK) Webinars

Clinical Practice Guidelines (CPGs) adopted

The Neurovascular Diseases Working Group (NEUROVASC-WG) follows (and have generated) existing (national and international) guidelines. The guidelines reflect the latest scientific evidence and are regularly reviewed and updated to ensure they remain up-to-date.

Result (1)
European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN)
March 27 2023

Bersano A, Khan N, Fuentes B, Acerbi F, Canavero I, Tournier-Lasserve E, Vajcoczy P, Luisa Zedde M, Hussain S, Lemeret S, Kraemer M, Herve D. European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy: Endorsed by Vascular European Reference Network (VASCERN). European Stroke Journal. 2023;0(0). doi:10.1177/23969873221144089

Skip to content